Fiske W - Search Results

1

The effects of ethanol on the bioavailability of oxymorphone extended-release tablets and oxymorphone crush-resistant extended-release tablets.

Fiske WD, Jobes J, Xiang Q, Chang SC, Benedek IH. Fiske WD, et al. J Pain. 2012 Jan;13(1):90-9. doi: 10.1016/j.jpain.2011.10.011. J Pain. 2012. PMID: 22208805 Free article. Clinical Trial.

2

Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release.

Benedek IH, Jobes J, Xiang Q, Fiske WD. Benedek IH, et al. Among authors: fiske wd. Drug Des Devel Ther. 2011;5:455-63. doi: 10.2147/DDDT.S24372. Epub 2011 Nov 23. Drug Des Devel Ther. 2011. PMID: 22162639 Free PMC article. Clinical Trial.

3

Distinguishing Ménétrier's disease from its mimics.

Rich A, Toro TZ, Tanksley J, Fiske WH, Lind CD, Ayers GD, Piessevaux H, Washington MK, Coffey RJ. Rich A, et al. Among authors: fiske wh. Gut. 2010 Dec;59(12):1617-24. doi: 10.1136/gut.2010.220061. Epub 2010 Oct 6. Gut. 2010. PMID: 20926644 Free PMC article.

4

Efficacy of cetuximab in the treatment of Menetrier's disease.

Fiske WH, Tanksley J, Nam KT, Goldenring JR, Slebos RJ, Liebler DC, Abtahi AM, La Fleur B, Ayers GD, Lind CD, Washington MK, Coffey RJ. Fiske WH, et al. Sci Transl Med. 2009 Nov 25;1(8):8ra18. doi: 10.1126/scitranslmed.3000320. Sci Transl Med. 2009. PMID: 20368185 Free PMC article. Clinical Trial.

5

ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Fiske WH, Threadgill D, Coffey RJ. Fiske WH, et al. Exp Cell Res. 2009 Feb 15;315(4):583-601. doi: 10.1016/j.yexcr.2008.10.043. Epub 2008 Nov 7. Exp Cell Res. 2009. PMID: 19041864 Free PMC article. Review.

6

Investigation of human pharmacoscintigraphic behavior of two tablets and a capsule formulation of a high dose, poorly water soluble/highly permeable drug (efavirenz).

Gao JZh, Hussain MA, Motheram R, Gray DA, Benedek IH, Fiske WD, Doll WJ, Sandefer E, Page RC, Digenis GA. Gao JZh, et al. Among authors: fiske wd. J Pharm Sci. 2007 Nov;96(11):2970-7. doi: 10.1002/jps.20962. J Pharm Sci. 2007. PMID: 17542016 Clinical Trial.

7

Chronic treatment of Ménétrier's disease with Erbitux: clinical efficacy and insight into pathophysiology.

Settle SH, Washington K, Lind C, Itzkowitz S, Fiske WH, Burdick JS, Jerome WG, Ray M, Weinstein W, Coffey RJ. Settle SH, et al. Among authors: fiske wh. Clin Gastroenterol Hepatol. 2005 Jul;3(7):654-9. doi: 10.1016/s1542-3565(05)00368-x. Clin Gastroenterol Hepatol. 2005. PMID: 16206497

8

Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.

Kapil R, Nolting A, Roy P, Fiske W, Benedek I, Abramowitz W. Kapil R, et al. Among authors: fiske w. Clin Ther. 2004 Dec;26(12):2015-25. doi: 10.1016/j.clinthera.2004.12.013. Clin Ther. 2004. PMID: 15823765 Clinical Trial.

9

Concurrent induction and mechanism-based inactivation of CYP3A4 by an L-valinamide derivative.

Luo G, Lin J, Fiske WD, Dai R, Yang TJ, Kim S, Sinz M, LeCluyse E, Solon E, Brennan JM, Benedek IH, Jolley S, Gilbert D, Wang L, Lee FW, Gan LS. Luo G, et al. Among authors: fiske wd. Drug Metab Dispos. 2003 Sep;31(9):1170-5. doi: 10.1124/dmd.31.9.1170. Drug Metab Dispos. 2003. PMID: 12920173

10

Population pharmacokinetic meta-analysis with efavirenz.

Barrett JS, Joshi AS, Chai M, Ludden TM, Fiske WD, Pieniaszek HJ Jr. Barrett JS, et al. Among authors: fiske wd. Int J Clin Pharmacol Ther. 2002 Nov;40(11):507-19. doi: 10.5414/cpp40507. Int J Clin Pharmacol Ther. 2002. PMID: 12698988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page